AI
AI Advancements Revolutionizing Regenerative Medicine
Insilico Medicine's Rentosertib, an oral small-molecule inhibitor for idiopathic pulmonary fibrosis (IPF), progressed from discovery to a Phase III clinical trial in record time.
Arjun Mehta·July 15, 2026
